Netherlands' Philips lifts annual profit, cash flow outlook after US tariff refund
Netherlands' Philips lifts annual profit, cash flow outlook after US tariff refund
Overview
Netherlands health tech firm's Q2 sales rose 4% yr/yr to EUR 4.4 bln
Operating income increased to EUR 609 mln, boosted by US tariff refund benefit
Comparable order intake fell 1% due to timing of large orders shifting to Q3
Outlook
Philips sees 2026 comparable sales growth outlook of 3%-4.5%
Company raises 2026 adjusted EBITA margin outlook to 13.5%-14.0%, including US tariff refund benefit
Philips increases 2026 free cash flow guidance to EUR 1.5-1.7 bln
Result Drivers
US TARIFF REFUND - One-off US tariff refund significantly boosted operating income and margins in the quarter
ORDER TIMING - Comparable order intake declined 1% due to timing of certain large orders
COST INFLATION AND TARIFFS - Excluding the US tariff refund, margins were pressured by cost inflation and higher tariffs, partly offset by productivity measures
Company press release: ID:nGNE7Y0wv4
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue |
| EUR 4.40 bln |
|
Q2 Operating Cash Flow |
| EUR 376 mln |
|
Q2 Free Cash Flow |
| EUR 222 mln |
|
Q2 Operating Income |
| EUR 609 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 12 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Koninklijke Philips NV is €27.25, about 15.8% above its July 27 closing price of €23.53
The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 15 three months ago
Reuters Recommended Reads
July 27 - AstraZeneca Q2 revenue rises 6% on demand for its cancer therapies
July 27 - Singapore's Raffles Medical H1 revenue falls 6.7%, profit down 9.8%
July 27 - US firms in Europe broadly see stable transatlantic ties a year on from trade deal
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Koninklijke Philips
See all newsBrief: Philips Launches Hypervue Integrated System In The U.S., Bringing Advanced Coronary Imaging And Physiology Into The Cathlab
Citi lifts ResMed's ASX-listed stock's target price after FX, valuation updates
Philips wins Dutch court battle with shareholders over recall
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
Brief: SA's Competition Commission Refers GE, Siemens, Philips Units To Tribunal For Alleged Anticompetitive Conduct